An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
PHASE3CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
November 30, 1997
Study Completion Date
July 31, 2000
Conditions
Mycoses
Interventions
DRUG
Voriconazole
Trial Locations (1)
20892
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00001757 - An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections | Biotech Hunter | Biotech Hunter